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Abstract
Angiogenesis of the microvasculature is central to the etiology of many diseases including proliferative retinopathy, age-
related macular degeneration and cancer. A mouse model of microvascular angiogenesis would be very valuable and
enable access to a wide range of genetically manipulated tissues that closely approximate small blood vessel growth in vivo.
Vascular endothelial cells cultured in vitro are widely used, however, isolating pure vascular murine endothelial cells is
technically challenging. A microvascular mouse explant model that is robust, quantitative and can be reproduced without
difficulty would overcome these limitations. Here we characterized and optimized for reproducibility an organotypic
microvascular angiogenesis mouse and rat model from the choroid, a microvascular bed in the posterior of eye. The
choroidal tissues from C57BL/6J and 129S6/SvEvTac mice and Sprague Dawley rats were isolated and incubated in Matrigel.
Vascular sprouting was comparable between choroid samples obtained from different animals of the same genetic
background. The sprouting area, normalized to controls, was highly reproducible between independent experiments. We
developed a semi-automated macro in ImageJ software to allow for more efficient quantification of sprouting area. Isolated
choroid explants responded to manipulation of the external environment while maintaining the local interactions of
endothelial cells with neighboring cells, including pericytes and macrophages as evidenced by immunohistochemistry and
fluorescence-activated cell sorting (FACS) analysis. This reproducible ex vivo angiogenesis assay can be used to evaluate
angiogenic potential of pharmacologic compounds on microvessels and can take advantage of genetically manipulated
mouse tissue for microvascular disease research.
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Introduction
Dysregulation of angiogenesis in microvessels is associated with
many sight-threatening vascular eye diseases such as diabetic
retinopathy (DR)[1], retinopathy of prematurity (ROP)[2] and
age-related macular degeneration (AMD)[3]. In addition, there
are many other diseases that have a microvascular component
including cancer[4], rheumatoid arthritis[5], psoriasis and the
healing process after stroke[6]. The development of an efficient
and reproducible assay modeling the microvascular bed would
enhance our ability to study microvascular diseases. Current
microangiogenic models using endothelial cells (ECs) in culture are
very useful but are limited by the lack of interactions with other
cells that are involved in angiogenesis, such as pericytes and
macrophages. These models are also hindered by the difficulty in
isolating mouse ECs, which might provide genetically altered cells
for study. The aortic ring assay in which isolated murine aortas are
cultured is very helpful for studying large vessel sprouting but may
not represent microvascular angiogenesis. To overcome these
limitations, we developed a sprouting model using choroidal tissue
that can easily be isolated from genetically modified mice to
explore microvascular angiogenesis.
The choroid is a vascular bed in the eye beneath the retinal
pigment epithelium (RPE) and supplies oxygen and nutrients to
the outer retina. It comprises a unique capillary meshwork with
the highest blood flow in the body[7]. The integrity of the
choroidal vasculature is vital to vision and abnormal angiogenesis
in the choroid is associated with ocular diseases such as age-related
macular degeneration (AMD)[3], retinitis pigmentosa (PR)[8],
diabetic retinopathy (DR)[9] and oxygen-induced retinopathy
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(OIR)[10]. Thus the choroidal microvascular tissue is involved in
many eye disease processes.
The choroid can be readily isolated from genetically modified
transgenic mice and therefore complements in vivo findings for
angiogenesis research. In culture the choroid rapidly develops
vascular sprouts that can be quantified with high reproducibility.
Our assay allows efficient evaluation of pharmacologic compounds
for their angiogenic potential. It is particularly useful for AMD
research since the blinding lesions of pathologic neovascularization
in neovascular AMD (i.e. wet AMD) originates from the choroid.
The choroidal sprouting assay addresses an unmet need for a
microangiogenesis model. It is complementary to the aortic ring
assay, the most widely used organotypic model of large vessel
angiogenesis. Like choroid explants, vascular sprouts from aortic
explants are composed of ECs, pericytes and macrophages[11].
Aortic explant sprouting can also be manipulated by exogenous
factors and the response can be quantified[12]. However, sprouts
from large vessels may differ from capillary networks involved in
microvascular pathology. ECs from different vasculature beds
display remarkably heterogenic structure, function, protein com-
position and mechanism of regulation[13,14]. For example, ECs
in arteries, veins and capillaries have different tolerances to
hydrostatic and oncotic pressure. Some are impermeable whereas
others allow easy exchange of gas and soluble substances with
extracellular fluid. Moreover, capillary ECs exhibit tissue-specific
differentiation patterns. In the central nervous system (CNS), such
as the brain and retina, ECs connect through tight junctions to
create the blood-brain/retina barrier ensheathed by glial cells
(astrocytes and Mu¨ller cells[15]). In contrast, in tissues like the
kidney capillaries are fenestrated to allow renal filtration. These
essential features of microvascular capillary networks may be
difficult to mimic using the macrovessels of aortic rings. The
choroidal sprouting assay is therefore likely to be more represen-
tative of microvascular angiogenesis, particularly of choroidal
tissue and fenestrated vessels.
Other in vitro systems of pure endothelial cell culture have been
widely used in studies of angiogenesis and enhance our under-
standing EC-specific signaling pathways. Cultured ECs allow
controlled manipulation of the extracellular environment to
investigate specific responses to cytokines, growth factors or drugs
during proliferation and differentiation. However, specific inhibi-
tion of a gene of interest in EC is usually not 100% complete with
small RNA interference. Furthermore, isolation and culture of
pure primary microvascular ECs from any mouse including
transgenic animals remain a challenge in vascular biology. Even if
successfully isolated from other animals, the primary ECs
differentiate after a few passages[16]. By growing ECs on
extracellular matrix (MatrigelTM) or gelatin, tube formation assays
can provide additional information about EC function[17].
Nevertheless these vascular tubes, although responsive to common
growth factors like vascular endothelial growth factor (VEGF),
often lack directional organization, making quantification of these
tube-like EC structures sometimes difficult[17].
Another common EC angiogenesis assay, the spheroid assay, is
also cultured on extracellular matrix[18]. Multicellular EC clumps
develop tube-like sprouts that project outwards from the central
cellular mass with densities proportional to the rate of EC
proliferation[19]. This assay of pure EC is more rigorously
standardized, but also lacks the interaction of ECs with other
perivascular cells and the problem of isolating ECs from
genetically altered mice remains. The choroid sprouting assay
was developed to overcome some of these limitations[20].
In this study, choroidal vascular tissue was isolated from
different strains of mice and from rats and was cultured ex vivo as a
model of a complex microvascular bed comprising many vascular
cells with their interactions intact. We standardized this assay with
respect to tissue preparation, intra- and inter- animal reproduc-
ibility, and reproducibility of pharmacological intervention on
proliferation. We developed a semi-automated method for efficient
and reproducible quantification of vascular sprouting in this assay.
This ex vivo choroid angiogenic assay can be used to complement in
vivo studies of microvascular behavior, particularly for neovascular
AMD studies, and provides a tool for the assessment of
pharmacologic compounds in angiogenic research.
Materials and Methods
Animals
Rodents used in this study were C57BL/6J (Jackson Laboratory)
mice, 129S6/SvEvTac (Taconic Farms, Inc.) mice and Sprague
Dawley rats (Charles River Laboratories). All studies adhered to
the Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision
Research and were approved by the Animal Care Committee of
Children’s Hospital or Hoˆpital Sainte-Justine. Animals were raised
in 12 hour light-dark cycles with free access to food and water.
Dissection of choroid tissue and culture preparation
Five minutes after injecting with Avertin, animals were
checked for responses and euthanized by cervical dislocation.
Eyes were immediately enucleated and kept in ice-cold medium
before dissection. The choice of the medium was identical to the
one used for incubation later. After removing the cornea and
the lens from the anterior of the eye, the central or peripheral
choroid-scleral complex was separated from the retina and cut
into approximately ,2 mm61 mm pieces (rats) or
1 mm61 mm (mice). Choroid/sclera (here on referred to as
‘‘choroid’’) fragments were isolated with and without RPE
removal by peeling RPE away with forceps and placed in
growth factor-reduced MatrigelTM (BD Biosciences, Cat.
354230) seeded in 24 well plates (Supporting Video S1).
30 mL of matrigel was used to coat the bottom of 24 well plates
without touching the edge of the well. The thickness of the
matrigel was approximately 0.4 mm. After seeding the choroid,
plates were incubated in a 37uC cell culture incubator without
medium for 10 minutes in order for the MatrigelTM to solidify.
500 mL of medium was then added to each well and incubated
at 37uC with 5% CO2 for 48 hr before any treatment. Medium
was changed every 48 hr. Phase contrast photos of individual
explants were taken daily using a ZEISS Axio Oberver.Z1
microscope. The areas of sprouting were quantified with
computer software ImageJ 1.46r (National Institute of Health).
The macro for SWIFT-Choroid quantification is available from
the authors.
FACS cell sorting analysis
After 6 days of incubation, the MatrigelTM embedding the
choroid explants was dissolved by dispase (BD Biosciences, Cat.
354235) at 37uC for 2 hours. The choroidal tissue was removed
from the medium by forceps and repeated pipetting separated
the sprouts. Phycoerythrin (PE) labeled anti-CD31 antibody and
Alexa Fluor 488 labeled isolectin GS-IB4 from Griffonia
simplicifolia (Life Technologies, Cat. I21411) were used to label
EC from the sprouts. Pure Human Umbilical Vein Endothelial
Cells (HUVEC; Lonza, Cat. C2519A) were used as a positive
control and Human Embryonic Kidney Cells (HEK293; Sigma-
Aldrich, Cat. 85120602) were used as a negative control for
staining. After 4 hours of staining, samples were washed 3 times
Microvascular Angiogenesis Assay
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for 10 minutes each with PBS. Fluorescence intensity was
monitored with a flow cytometer (BD Biosciences, Lincoln Park,
NJ) and data were analyzed using the Flowjo software (Tree
Star, Inc.).
Immunohistochemistry
After 4 days of incubation, choroidal and aortic ring tissue with
endothelial sproutings was washed once with ice-cold phosphate
buffered saline (PBS). Paraformaldehyde (PFA) (4% solution) was
then added for 10 minutes before treatment with Alexa Fluor 594
conjugated isolectin GS-IB4 from Griffonia simplicifolia (Life
Technologies, Cat. I21413) and 49, 6-diamidino- 2 phenylindole
(DAPI), chondroitin sulfate proteoglycan neuron-glial antigen 2
(NG2; Chemcon, Cat. AB5320), Desmin (Abcam, Cat. Ab15200)
or Alexa Fluor 488 conjugated CD68 (AbD seroTec, Cat.
MCA1957A488).
Real-time PCR
After 6 days of incubation, the sprouting cells from choroid and
aortic ring explants were isolated as described for FACS analysis.
mRNA of the sprouts was extracted by RNeasyH kit (Qiagen, Cat.
74104) following the manufacture’s protocol. Total RNA (1–5 mg
per sample) was diluted into a volume of 15 mL and incubated at
70uC for 10 minutes to dissociate the secondary structure. A master
mix of 6 mL of 56 first strand buffer, 3 mL of DTT, 2 mL of dNTP,
1 mL of RNase and 1 mL of oligo-dT with 2 mL of M-MLV reverse
transcription enzyme was added to the diluted RNA sample and
incubated at 42uC for 60 minutes followed by 5 minutes of
inactivation at 94uC. These cDNA samples were then mixed with
26QuantiTect SYBER PCR Master Mix and primer pairs for the
quantitative measurement of corresponding gene expression.
Primer sequences were CD31: 59- GAGCCCAATCACGTTT-
CAGTTT-39 (forward) and 59- TCCTTCCTGCTTCTTG-
CTAGCT-39 (reverse); VE-Cadherin: 59- TCCTCTGCATCCT-
CACTATCA CA -39 (forward) and 59- GTAAGTGAC-
CAACTGCTCGTGAAT-39 (reverse); NG2: 59- GGGCTGTG
CTGTCTGTTGA-39 (forward) and 59- TGATTCCCTTCAGG-
TAAGGCA-39 (reverse); CD68: 59- CAC CACCAGTCATGG-
GAATG-39 (forward) and 59- AAGCCCCACTTTAGCTT-
TACC-39 (reverse); Tie-2: 59- GAGTCAGCTTGCTCCTT-
TATGG-39 (forward) and 59- AGACACAAGAGGTAGG-
GAATTGA-39 (reverse).
SWIFT-Choroid computerized quantification method
(Available to academic institutions through the authors). We
developed an alternative computerized method to measure only
the area in the choroidal sprouting assay covered by growing
vessels. The pre-edited SWIFT-Choroid macros were copied into
the plugin folder of ImageJ 1.46r (NIH) software and the
appropriate shortcut for each macro was assigned. A phase
contrast choroid sprouting image was opened with ImageJ and the
magic wand function of the software was used to outline the
choroid tissue in the center of the sprouts. The tolerance rate of
the magic wand was set to 30%. The first macro deleted the
choroid from the original image and read the choroid area in pixel
units. The threshold function was then used to define the
microvascular sprouts against the background and periphery.
The free selection tools removed the background of the image.
The second macro calculated the number of threshold-outlined
pixels and saved an image of the selected area in the same folder as
the original picture for future reference. After a group of samples
was measured, the recorded measurements were copied into
Microsoft excel for future analysis.
Culture Medium
The choroidal tissue was incubated in CSC complete medium
(Cell Systems, Cat. 420-500) activated with either growth factor
Boost, EGM-2 medium with endothelium growth medium
(EGM) kit and 5% FBS (Lonza, Cat. CC-3156) or DMEM high
glucose with 10% FBS (GIBCO, Cat. 11885). All media
contained 50 units/mL of Penicillin/Streptomycin (GIBCO,
Cat. 15142) and 5 mg/mL of PlasmocinTM (Invitrogen, Cat.
Ant-mpt).
Trypsin digestion and removal of RPE cell layer
Adapted from previously published RPE isolation protocol[21],
dissected RPE-choroid-scleral tissue was digested in 0.25%
Trypsin (GIBCO, Cat. 15050-065) at 37uC for 10 to 40 minutes.
After incubation, the RPE cells were removed under a microscope
(ZEISS, SteREO Discovery.V8) using micro-forceps.
Pro- and anti-angiogenic drug treatment
When treating the choroidal sprouts with VEGF (R&D system,
Cat. 293-VE), the tissue was first incubated in complete medium
for 48 hours and then starved in the absence of growth factors for
4 hours. Then 10 ng/ml, 50 ng/ml and 250 ng/ml of VEGF
were added to growth factor reduced medium: For CSC medium
a 1:200 dilution of Boost was used instead of 1:50 and 2.5% FBS
was added to EGM-2 medium instead of 5%. When treated with
anti-angiogenic factor 4-hydroxy-docosahexaenoic acid (4-
HDHA) (3–15 mM; Cayman, Cat. 33200), the tissue was first
incubated in complete medium for 72 hours before treatment of
the samples. The vehicles of corresponding drugs (PBS for VEGF
and ethanol for 4-HDHA) were used as controls.
Statistical Analysis
Data are presented as mean 6 SEM for all histograms unless
otherwise indicated. Comparisons between groups were made with
either 2-tail unpaired student’s T-test or analysis of variance
(ANOVA), followed by post-hoc Bonferroni correction for
comparison among means. P,0.05 is considered statistically
significant.
Results
Comparison and consistency of central vs. peripheral
choroid sprouting
We dissected the choroid attached to sclera from the retina in
mouse and rat eyes, embedded fragments of the choroidal tissue in
MatrigelTM and cultured them for 4–6 days (Figure 1 &
Supporting Video S1). Various parameters that potentially
impact the reproducibility and the quantification of the assay were
investigated (Table 1). Choroidal fragments from the central
region adjacent to the optic nerve head sprouted more slowly and
less consistently than those from the peripheral region adjacent to
the ora serrata (Figure 2A&B). Therefore, choroidal tissue
fragments must be obtained at the same radial distance from the
optic nerve head (depending on area of interest) for consistency of
the assay in both mice and rats. The mean and variation of
sprouting area of the choroid samples obtained from the same eye
of the same animal (intra-animal) were comparable to the
sprouting area of samples from different animals (inter-animal)
(Figure 2D), suggesting that data from inter-animal and intra-
animal samples can be pooled for analysis. Interestingly, within the
tested tissue punch size (i.e. 0.2 mm2 to 0.8 mm2) the size of the
choroid tissue implanted did not impact the vessel-sprouting area
(Figure 2E & Supporting Figure S2A). This evidence
Microvascular Angiogenesis Assay
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demonstrates that technical variation in choroid tissue dissection
within these parameters does not cause variation in the assay.
Sprouts consist of ECs, pericytes and monocytes/
macrophages
FACS cell sorting analysis indicated that approximately 60% of
the cell populations of the sprouts stain positively with anti-CD31
antibody (Figure 2C & Supporting Figure S1A). CD31 serves
as a biomarker of ECs but may also be expressed in some
macrophages. The vascular sprouts from the choroid were tube-
like growth cones of ECs (positive for isolectin GS) surrounded by
pericytes (positive for chondroitin sulfate proteoglycan neuron-glial
antigen 2 (NG2)) (Figure 2D). Compared to the aortic ring assay,
the choroidal sprouts expressed similar quantities of endothelial
markers (i.e. VE-cadherin and Tie-2) when normalized to CD31
(Figure 2E & Supporting Figure S1D). Higher mRNA
expression of NG2, a microvascular morphogenesis marker, was
detected in choroidal sprouts compared to aortic ring sprouts
(Figure 2F), indicating that the choroidal sprouts were indeed
microvessels. A population of isolectin and CD68-positive cells was
also detected in the sprouts adjacent to planted choroidal tissue,
but not at the tips of the sprouts. These isolectin and CD68-
positive cells exhibited monocyte/macrophage-like cell morphol-
ogy (Supporting Figure S1B). Compared to aortic ring sprouts,
the expression of CD68 was much higher in the choroidal sprouts
(Supporting Figure S1E). The latter observations were
consistent with what appears to occur in choroidal neovascular-
ization in vivo [22]. Aortic ring sprouts were less differentiated and
contained cells positive for both EC specific stain, Isolectin and
pericyte marker, Desmin (Supporting Figure S1C). Important-
ly, the choroidal sprouting area was not affected by the size of the
choroidal tissue implanted (between 0.2 mm2 to 0.8 mm2)
(Figure 2G & Supporting Figure S2A).
The choroid sprouting assay is highly reproducible
Traditionally, the sprouting area of endothelial organotypic
culture is quantified by subtracting the area of the tissue explant
from the total area occupied by the sprouts [10,23]. The
percentage change in sprouting areas in response to angiogenic
stimuli compared to controls was highly reproducible between
replicates (175626% vs. 172614%) (Figure 3A). However,
absolute sprouting areas between independent experiments were
slightly different (Supporting Figure S2C), reflecting the slight
natural variation of tissue preparation and culture conditions from
experiment to experiment, and indicating the importance of
normalizing to control within each experiment. Because the
sprouting area did not correlate with the size of the choroid tissue
implanted (Figure 2E & Supporting Figure S2A), we
confirmed that the area of the explanted tissue should be
subtracted from the sprouting area [10,23] and should be
normalized to the control groups within the same experimental
set. The area of explanted tissue should not be used to normalize
the sprouting area. (Because the data points were normally
distributed, we used the Student’s T-test and Analysis of Variance
(ANOVA) to examine the statistical significance between groups
(Supporting Fig. S2D).
Standardized quantification of sprouting (Macros
available from the authors)
(Macros available from the authors.) To increase the efficiency
and accuracy of the quantification we developed a computerized
SWIFT-Choroid method that uses pre-installed macros for ImageJ
software to calculate the area of fine vascular sprouts without
including the space between vessels observed with manual
quantification (Figure 3B & C). Hence, the absolute reading
differed between the manual (including the extracellular space)
and SWIFT quantification methods (excluding the extracellular
space; Figure 3D). After normalization of each treatment group
to the control group, however, the results from the two
quantification methods were highly consistent (46.668.1% using
Figure 1. Schematic illustration of the choroid sprouting assay. Eyes are first enucleated from the mice and an initial incision is made along
the corneal limbus. A micro-scissor is then used to cut 0.5 mm posterior to the corneal limbus in order to remove the cornea/iris complex and the
lens. An incision perpendicular to the corneal limbus towards the optic nerve is made. After peeling off the retina from RPE/choroid/sclera complex,
the central and peripheral regions of the complex are separated and further cut into approximately 1 mm61 mm pieces and embedded in matrigel.
The microvascular sprouts from the choroid tissue is visualized under a microscope.
doi:10.1371/journal.pone.0069552.g001
Table 1. Choroid Sprouting Standardization and
Optimization
Species Rats vs. Mice
Region of Choroid Central vs. Peripheral
Normalization Absolute Area vs. Relative to Control
Quantification Manual vs. SWIFT
Impact of RPE With RPE vs. Without RPE
Medium EC selective vs. Non-selective
Age Young vs. Old
Strain 129S6 vs. C57BL/6J
Drug Treatment Pro-angiogenic vs. Anti-angiogenic
doi:10.1371/journal.pone.0069552.t001
Microvascular Angiogenesis Assay
PLOS ONE | www.plosone.org 4 July 2013 | Volume 8 | Issue 7 | e69552
Figure 2. Mouse and rat central and peripheral choroid sprouting: intra- and inter-animal variability. (a) Five replicates from 5 animals
were compared for the intra-animal (from the same eye of the same animal) variability and inter-animal variability of choroid sprouting. Scale bar:
500 mm. (b) The sprouting from the peripheral mouse choroid is more consistent than central mouse choroid (n = 5) (c) Flow cytometry analysis of
choroid sprouting cell populations. About 60% of the cell population from the choroid sprouts stained positive for both CD-31 and isolectin,
indicating ECs/macrophages. 36% of the cell population is isolectin-positive but did not stain for CD-31. (d) The extending growth cone resembles
vascular tube formation in vivo and stains positively with isolectin GS (arrow head) surrounded by chondroitin sulfate proteoglycan neuron-glial
antigen 2 (NG2) positive pericytes (arrow). Scale bar: 10 mm. (e) Real time-PCR analysis of choroid sprouts and aortic ring sprouts indicates that the
expression of endothelial marker VE-cadherin is not significantly different between the two assays when normalized to CD31 expression (n = 12)
p = 0.97; unpaired T-test. (f) The expression of NG2 by real time PCR is higher in choroid sprouts compared to aortic ring sprouts (n = 8) *** p,0.0001;
unpaired t-test. (g) The rate of choroid sprouting is not correlated to the size of the choroid tissue embedded within the rage of 0.2 mm2 to 0.8 mm2.
doi:10.1371/journal.pone.0069552.g002
Microvascular Angiogenesis Assay
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manual quantification and 46.968.1% using SWIFT-Choroid)
(Figure 3E). As expected, the SWIFT-Choroid computer-image
analysis method was ,10 times faster than the manual approach
(,2 minutes versus ,20 minutes per photo using manual
quantification).
Influence of retinal pigment epithelium (RPE) on the
choroid sprouting assay
A. RPE potentiates endothelial sprouting in endothelium
specific media. Retinal pigment epithelium (RPE) is a single
layer of pigmented cells lying between the photoreceptors of the
retina and choriocapillary bed. It plays a crucial role in
maintaining the visual circle by phagocytizing the outer segment
of the photoreceptors and converting all-trans-retinal to 11-cis-
retinal. The RPE and choroidal vessels are known to interact such
that the RPE exerts both pro- and anti-angiogenic effects [24] by
releasing both pro- and anti- angiogenic factors like vascular
endothelial growth factor (VEGF) and pigment epithelial derived
factor (PEDF) [25]. Choroidal tissue with or without the RPE
attached can be used in the choroid sprouting assay. We compared
the sprouting of the choroid with and without RPE in different
media, and with trypsin removal of RPE to assess the effect of
trypsin on the assay.
Sprouting from choroidal tissue without RPE was significantly
slower in EC specific media such as CSC medium (Figure 4A)
and EGM-2 medium (Figure 4B), but not in non-selective cell
medium such as DMEM medium (Figure 4C). Therefore, the
RPE-choroid co-explant assay can be used to analyze the RPE-
choroid interaction and its response under different conditions.
For instance, to understand the impact of a drug on choroid vessels
alone, one may use choroidal tissue with the RPE removed to
conduct the sprouting assay. In another case, if one is interested in
the impact of the RPE-derived factors on choroid angiogenesis,
conditional gene knockout in RPE cells may be studied in choroid
explants with the RPE left in place. The sprouting in DMEM
medium did not display tube-like structures and contained RPE-
like cellular debris adjacent to the explanted tissue (Figure 4C).
These results suggest DMEM may promote RPE proliferation and
may not be ideal to support vascular cell interactions that give rise
to vascular tubes.
B. Trypsin (used to remove RPE) does not influence the
choroid sprouting assay. To completely remove the RPE
layer, RPE-choroid tissue may be treated with trypsin to dissociate
RPE from choroid before explanting. Since trypsin could activate
pro-angiogenic receptors and promote vascular proliferation [26],
the potential angiogenic effect of trypsin was examined in the
choroid sprouting assay. After 10–40 minutes of incubation, no
appreciable difference was detected with or without trypsinization,
demonstrating that 20 minutes of trypsin treatment per se does not
significantly affect choroid sprouting (Supporting Figure S3). A
short incubation time of 10 minutes incompletely dissociates RPE
and therefore induces high variation in sprouting rate, whereas a
longer incubation of 40 minutes changes the texture of the
choroidal tissue. Hence, a 20-minute incubation time is recom-
mended if trypsinization is necessary.
Choroid tissue from aging animals sprouts more slowly
than from young animals
Choroidal vascular degeneration and later-stage central choroi-
dal neovascularization are prominent features of AMD [27]. To
assess the influence of aging on choroidal endothelial proliferation,
the choroidal tissue from young and aged animals was isolated.
The choroid from older animals (postnatal day (P) 240, i.e. 8
months old) sprouted more slowly than choroid from P8 pups.
This age-dependent difference in sprouting was RPE independent
(12.468.5 vs. 69.568.6 with RPE and 18.366.0 vs. 43.767.1
without RPE) (Figure 5A & B). Previous studies in neonatal rats
indicate that the choroid vascular bed continues to grow during
the first two weeks of postnatal development [10], which
rationalizes why the choroid from P8 mice sprouts faster than
choroid tissue from P19 mice. Since aging in general suppresses
the proliferative capacity of cells, the findings here may suggest a
decreased ability of reparative angiogenesis in aging choroidal
endothelium.
Strain difference: choroidal tissue from 129S6/ScEvTac
mice sprouts faster than that from C57BL/6J mice
The normal retinal vascular development in various mouse
strains varies significantly [28]. We investigated the choroid
sprouting response of 129S6/SvEvTac mice compared to C57BL/
6J mice. After 7 days of incubation, the choroid explants from
129S6/SvEvTac animal grew significantly faster than choroid
obtained from C57BL/6J mice (213.3612.7 vs. 172.9611.3
respectively; Figure 5C).
Pharmacological intervention in the choroid sprouting
assay is reproducible
VEGF is a well-studied pro-angiogenic molecule [29]. In
addition, our previous study indicated that 4-hydroxy-docosahex-
aenoic acid (4-HDHA), a lipid metabolite of dietary v-3
polyunsaturated fatty acids (PUFAs), inhibits EC proliferation in
both the spheroid and aortic ring assays [30]. Here we tested
VEGF and 4-HDHA in the choroid sprouting assay. VEGF
promoted sprouting in the choroid assay in a dose-dependent
manner (Figure 6A). Furthermore, 4-HDHA reproducibly and
dose-dependently suppressed choroid sprouting (Figure 6B),
suggesting that the choroid sprouting assay can be used to assess
the angiogenic potential of pharmacologic compounds.
Discussion
Here we report the development and standardization of an
organotypic microvascular sprouting assay that can be obtained
from the choroid of transgenic mice to evaluate the effect of
genetic manipulation on microvascular proliferation. This assay is
highly reproducible and pertinent to angiogenesis research,
particularly in the neovascular AMD field. Additionally, we
evaluated the effects of age, region of the choroid and specific
endothelial growth media on the assay. The choroid sprouting
assay can be used to evaluate pro- and anti-angiogenic pharma-
cological interventions. Importantly, the choroid sprouting assay
allows for analysis of the interaction between choroidal endothelial
cells and their adjacent cells (e.g. RPE cells) to uncover
mechanisms that control choroidal vascular growth of specific
relevance (but not exclusively) to sub-retinal proliferative disorders.
We also described a reproducible and semi-automatic method that
standardizes quantitative analysis of choroidal sprouting area.
In this study, we discovered that different culture media affects
the outcome of the choroid sprouting assay. In previous ex vivo
assays, DMEM was used [31]. However, we found that DMEM is
not formulated for optimal EC growth as it promotes proliferation
of other types of cells (such as RPE), which influence vascular
proliferation (Figure 4C). Therefore DMEM is unsuitable for the
choroid sprouting assay. Various EC specific culture media have
been suggested for ex vivo vascular cultures, including MCDB 131
medium [32] and EGM-2 medium [30,33]. CSC complete
medium is a modified and optimized DMEM/F12 (1:1) medium
containing 10% of serum by volume and endothelial growth factor
Microvascular Angiogenesis Assay
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Figure 3. Computerized and manual choroid assay quantification methods yield reproducible and comparable normalized results.
(a) The percentage change between control and treatment groups was highly reproducible between independent experiments run at different times;
(n = 6–12) ** p = 0.0042; 2-way ANOVA with Bonferroni correction; (b) Representative photos demonstrate manual and computerized quantification of
choroid endothelial sprouts. Scale bar: 500 mm. (c) A step-by-step demonstration of SWIFT-Choroid method quantifying the area of the sprouts. (c1)
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The area of the choroid tissue was first selected by the magic wand tool from the ImageJ software. (c2) Step 1 of the macro was then used to delete
the choroid tissue from the image and calculate the choroid area in pixels. (c3) The excess area of the image was then removed using the polygon
selection tool and (c4) the threshold function and the second step of the macro was followed to calculate the sprouting area in pixels. (d) The SWIFT-
Choroid method calculates sprouting area without extracellular space. The absolute value of the calculated area is 2.2760.26 mm2 for manual
(n = 11) versus 0.8760.09 mm2 (n= 11) *** p,0.0001; unpaired t-test. (e) However, the differences between control (n = 11) and treated groups
normalized to respective controls (n = 12) were similar for each method: 46.668.1% using manual quantification and 46.968.1% using SWIFT-
Choroid. *** p,0.0001 between treatment group and control group, p = 0.986 between quantification methods; 2-way ANOVA.
doi:10.1371/journal.pone.0069552.g003
Figure 4. RPE cells promote choroidal endothelial sprouting in endothelial-selective media. Three different cell culture media (CSC, EGM-
2 and DMEM) were compared for standardizing choroidal tissue response. (A) Complete CSC medium with growth factor Boost promotes rapid
sprouting. An intact RPE layer on choroid further accelerates sprouting (n = 5–12) p,0.0001 compared to choroid without RPE. (B) RPE cells also
potentiate choroid sprouting in EGM-2 medium (n= 6 for each time point) p,0.0001, (C) However, in DMEM there is no difference in sprouting rate
(n = 6–18, p = 0.1) regardless of the presence of RPE. The sprouting in DMEM medium contained RPE-like contamination (arrows) and the sprouts did
not form growth cones as shown in CSC or EGM-2 medium. All comparisons are 2-way ANOVA with Bonferroni correction. Scale bar: 500 mm.
doi:10.1371/journal.pone.0069552.g004
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Figure 5. The age and strain of the animal affects the rate of choroidal sprouting in explant culture. (A&B) Choroid with or without RPE
from P8 animals sprouts significantly faster than that from P240 aging animals (n = 6–18, p,0.0001 with RPE; n = 6–12, p = 0.0002 without RPE). (C)
The choroid explants from 129S6/SvEvTac mice (n = 10) grow significantly faster than choroid explants from C57BL/6J mice (n = 12) at day 7
p= 0.0017. All comparisons are 2-way ANOVA with Bonferroni corrections.
doi:10.1371/journal.pone.0069552.g005
Figure 6. Choroid sprouting assay responds dose-dependently to pro- and anti-angiogenic factors. (A) Choroid sprouting increases with
increasing doses of VEGF (n = 8 for each time point). After 4 days of incubation, 250 ng/mL of VEGF increased the sprouting compared to vehicle
treated control *** p,0.001. (B) After treating with 4-HDHA, the sprouting rate decreased as the concentration of 4-HDHA increases. At 15 mM 4-
HDHA, the existing sprouts regressed over time (n = 4–8 for each treatment group) p,0.0001 between different 4-HDHA doses. All comparisons are
2-way ANOVA with Bonferroni correction.
doi:10.1371/journal.pone.0069552.g006
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boost, which is designed for primary ECs and provided the
optimum sprouting for the choroid explants.
Our results also show that RPE cells promote choroidal vascular
proliferation under some specific culture medium conditions,
consistent with the proliferative effects of RPE on EC spheroids
grown on a monolayer of RPE cells [19]. Hence, the assay we
describe (with and without RPE) provides another tool to study
RPE-choroidal interaction particularly in AMD studies. Since
choroidal involution and central choroidal neovascularization are
associated with AMD and aging [34], we investigated the impact
of age on choroidal vascular proliferation. Aging choroid sprouts
more slowly than choroid from newborn and juvenile mice. This
phenomenon is consistent with choroidal involution seen in the
dry form of AMD with geographic atrophy [27]. Among AMD
patients, 85–90% have dry AMD [35]. The choroid sprouting
assay may be a versatile tool to facilitate investigations on
mechanisms underlying AMD pathogenesis.
An ex vivo incubation of choroidal tissue was first described by
Kobayashi et al. [31,36–38]. These studies used isolated choroid to
test pharmacological interventions with the potential to treat DR
and AMD. The assay was quantified by counting the number of
vessels. We have characterized the choroid assay in more detail
and standardized the quantification method. In our study, we
found that the growth rates of replicates normalized to controls
within an experiment are highly consistent (Figure 2b) and
comparisons between normalized, treated groups in separate
experiments are very reproducible (Figure 3a).
This assay of microvascular angiogenesis is likely to be a useful
addition to other assays. Culture of pure vascular ECs in vitro is
limited as a microvascular assay in large part because of the
difficulty in isolating mouse ECs, which is important for evaluating
the impact of genetic manipulation on angiogenesis of transgenic
mice. Although useful as an assay examining effects of interventions
on EC biology, cultured primary ECs may undergo phenotypic
drifts, including changes in ion channel expression and function,
calcium homeostasis, as well as ECs specific protein expression
[20,39]. Such heterogeneity is affected by the autocrine action of
growth factors, hormones and vasoactive substances [40,41] and
explains in part the variability and occasional inconsistencies
reported with these cells. Furthermore, in the absence of their
interactive partner cells and extracellular matrix in vitro cultures of
ECs may lose many of their physiological properties, such as the
ability to form vascular tubes [42]. The aortic ring assay is very
useful to assess sprouts from large vessels from mice but may not
accurately reflect a tissue-specific microvascular response [43].
In summary, this study characterized and standardized a highly
reproducible, efficient and quantifiable choroid microvascular ex
vivo sprouting assay that can be obtained from rat and transgenic
mice to study microvascular angiogenesis (Table 2). This method
provides a new experimental tool not only for AMD studies, but
also for physiological and pharmacological research related to
microvascular diseases in general.
Supporting Information
Figure S1 (A) Flow cytometry analysis of sprouts with R-
phycoerythrin (PE) labeled anti-CD31 antibody confirms that over
half of the cell population is CD31 positive. (B) Adjacent to
choroid tissue, a small population of CD68 and isolectin positive
cells was detected. These cells also exhibit the morphology of
monocytes/macrophages. (C) The cells composing aortic ring
sprouts are less differentiated and express both EC marker
Isolectin and Desmin. (D) Real time-PCR analysis of choroid
sprouts and aortic ring sprouts indicates that the expression of
endothelial marker Tie-2 is not significantly different between the
sprouts of two assays (n = 8) p = 0.143; unpaired T-test. (E) The
expression of CD68 tested by real time PCR is significantly higher
in choroid sprouts compared to aortic ring sprouts indicating that
there is a larger macrophage population present in the choroid
assay comparing to the aortic ring assay (n = 12) *** p,0.0001;
unpaired t-test.
(TIF)
Figure S2 (A) The rate of choroid sprouting is not correlated
with the size of the choroid tissue embedded using choroid from
the central regions of the eye. (B) Impact of initial sprouting rate.
(C) The absolute choroid sprouting areas in mm2 between
independent experiments could be significantly different (two
independent experiments conducted 2 days apart) (n = 11 for
control and n= 6 for treatment) ** p = 0.0058; unpaired t-test. (D)
Samples from the control group and the treated groups are
normally distributed indicating that statistical analysis that assumes
normal distribution of the samples can be used in this study.
(TIF)
Figure S3 Trypsin, used to remove RPE, does not affect choroid
sprouting (n = 3 for each time point) p = 0.1225 between different
groups, 2-way ANOVA with Bonferroni correction. However, a
10 min incubation incompletely dissociates RPE, causing incom-
plete removal of RPE which induces high variation in sprouting
rate, whereas long-term incubation (i.e. 40 min) changes the
texture of choroid tissue. Hence, 20 min incubation is recom-
mended for trypsinization.
(TIF)
Video S1 Demonstration of isolation of choroid from the mouse
eye.
(MOV)
Table 2. Suggested Conditions for Choroid Microvascular Sprouting Assay
Region of Choroid Peripheral choroid
Normalization Relative to control within the same batch
Quantification SWIFT-Choroid semi-automated quantification
Trypsinization No trypsinization if possible or 20 min 0.25% Trypsin at 37uC
Medium EC selective media
Age P20 for optimum growth rate
Strain Consistent background between wild type and transgenic animals
doi:10.1371/journal.pone.0069552.t002
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